Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
W
Walia, Rama
Post Graduate Institute of Medical Education and Research
(
W1530-02-08
)
Non-invasive Molecular Imaging of V3 Receptors to Localize ACTH-Dependent Cushing's Syndrome and Precision Surgery of Corticotropinoma
Rama Walia
Favorite
Wallace, Nicole
AstraZeneca
(
T1330-01-03
)
Stain-Free Approach to Determine and Monitor Cell Heath Using Supervised and Unsupervised Image-Based Deep Learning
Nicole Wallace
Favorite
Wang, Bei
Genentech, Inc.
(
T1530-02-08
)
Cross Validation of Pharmacokinetic Assays: Experimental and Statistical Design
Bei Wang
Favorite
Wang, Hongzhi
Genentech, Inc.
(
T1530-02-07
)
Integrated HypoSkin® Model and PBPK Modeling as a Bioavailability Predicting Tool for Subcutaneous Delivery of Protein Therapeutics
Hongzhi Wang
Favorite
Wang, Xiangdan
Biopharmaceutical Research Inc.
(
T1330-02-08
)
Production and Characterization of Critical Biotin and DIG Conjugated RESCA-Anti-CD8 VHH Reagents to Enable the Non-Clinical and Clinical Anti-Drug Antibody Assay Development
Xiangdan Wang
Favorite
Watkinson, Allan
LabCorp
(
T1330-01-02
)
Formulation Development and Characterization of a Marburg Self-amplifying mRNA-Lipid Nanoparticle Vaccine with a Toll-Like Receptor 7 Agonist
Allan Watkinson
Favorite
(
T1530-02-11
)
Formulation Development and Characterization of a Marburg Self-amplifying mRNA-Lipid Nanoparticle Vaccine with CpG Oligonucleotide
Allan Watkinson
Favorite
(
W1230-01-05
)
Development of a Marburg Self-amplifying mRNA-Lipid Nanoparticle Vaccine: Differential Effects When Co-formulated with Toll Receptor Agonists
Allan Watkinson
Favorite
Weaver, Jessica
BioAgilytix Labs
(
W1530-02-09
)
Development of Non-Cell Based Potency Assays for Bispecific Antibodies
Jessica Weaver
Favorite
Webb Vargas, Yenny
Genentech, Inc.
(
T1330-02-07
)
Optimizing and Validating an In Vitro Transcytosis Assay for Predicting Pharmacokinetics in Drug Discovery and Process Development
Yenny Webb Vargas
Favorite
Weimbs, Thomas
University of California Santa Barbara
(
W1430-02-07
)
Novel Use of Recombinant Dimeric IgA Monoclonal Antibodies as Cyst-Targeted Therapeutics in Polycystic Kidney Disease
Thomas Weimbs
Favorite
Wen, Shirley
AliveX Biotech
(
T1030-02-06
)
A Mechanistic Model of IgG4-RD Identifies High-Potential Therapy Targets
Shirley Wen
Favorite
Wilcox, Paige
AstraZeneca
(
T1330-01-03
)
Stain-Free Approach to Determine and Monitor Cell Heath Using Supervised and Unsupervised Image-Based Deep Learning
Paige Wilcox
Favorite
Woon, Nicholas
Genentech, Inc.
(
T1430-01-03
)
Val-His-Ser (VHS) N-terminal Leader Sequence and Implications for mAb Subcutaneous Pharmacokinetics
Nicholas Woon
Favorite
Worrell, Gregory
Mayo Clinic
(
W1430-01-04
)
Innovative Device for Concomitant Therapeutic Compound Delivery into the Brain and Neural Recordings - Feasibility Bench and In Vivo Studies
Gregory Worrell
Favorite
Wu, Benjamin
Genentech, Inc.
(
T1230-02-09
)
Population Pharmacokinetics and Exposure-Efficacy and -Safety Analyses of Atezolizumab for Subcutaneous Injection in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer
Benjamin Wu
Favorite
